The Atlantic Pediatric Device Consortium (APDC) is one of seven FDA funded pediatric device consortia awarded in 2013. A collaboration between Georgia Tech, Emory University, Children's Healthcare of Atlanta and Virginia Commonwealth University, APDC provides a national platform to translate ideas through its product development pathway all the way to commercialization. The mission of APDC is to enhance the lives of children through the development of novel pediatric medical devices, which are both safe and effective.
The mission of the Center for Pediatric Innovation (CPI) is to develop new medical devices, therapeutics, and regenerative medicine strategies to address grand challenges and unmet clinical needs in pediatric healthcare.
In 2011, Children's premiered the first Center for Pediatric Nanomedicine (CPN) in the nation. This effort is led in conjunction with Emory, Georgia Tech and Morehouse. Nanotechnology is the science of manipulating materials, structures and devices at the molecular level. Nanomedicine uses this technology to diagnose, treat and cure damaged tissue or disease. The Center for Pediatric Nanotechnology is committed to developing nanomedicine to its full potential.
The Center for Transforming Pediatric Healthcare Delivery (CTPHD) connects industry, government and nonprofit leaders with Georgia Tech’s world-class researchers and innovations to transform media, health, education and humanitarian systems. CTPHD integrates academic and applied research through living laboratories and multidisciplinary projects to deliver real-world, transformative solutions that balance the needs of people with the possibilities of new technologies.
The Chiari & Syringomyelia Foundation seeks to find a cure for chiari malformation (CM), syringomyelia (SM) and related disorders.
Children's Healthcare of Atlanta (CHOA) is partnered with the Georgia Institute of Technology. CHOA is a pediatric physician teaching site for the Emory University School of Medicine and the Morehouse School of Medicine. Children are not just small adults. They belong in a children’s hospital where they can get a specialized diagnosis, treatment, equipment and support. Children should be cared for by pediatric doctors, nurses and specialists who understand these differences. With a track record of providing world-class care to its patients in more than 30 pediatric specialties, Children's is a model for other pediatric hospitals.
The Emory+Children’s Heart Research and Outcomes Center (HeRO) seeks to reduce the morbidity of pediatric heart disease. As our ability to detect and repair congenital heart defects has improved over the years, these patients now require long-term solutions to improve cardiac function.
The Georgia Clinical & Translational Science Alliance (Georgia CTSA) is an inter-institutional magnet that concentrates basic, translational, and clinical research investigators, community clinicians, professional societies, and industry collaborators in dynamic clinical and translational research projects. Emory engaged three of its close academic partners - Morehouse School of Medicine (MSM), Georgia Institute of Technology (Georgia Tech), and the University of Georgia (UGA) - to form the Georgia CTSA. This partnership, a strategic multi-institutional alliance, offers compelling, unique, and synergistic advantages to research and patients statewide.
Ian’s Friends Foundation is committed to funding the support of pediatric brain tumor research. Their mission is to undertake and support initiatives at research institutions around the country that focus on developing new therapeutic methodologies for the treatment of pediatric brain tumors.
The Wallace H. Coulter Foundation provides leading scientific and medical societies the resources to develop distinctive educational programs designed to improve the quality of care in resource-limited areas. Its university-based translational research grant programs establish a business-like process to accelerate academic innovations to the marketplace.